Skip to content
Disclosery

EXANE DERIVATIVES: CF position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CF, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5,367 CF shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5,367 shares
    Change vs previous 13F -1,946 shares

    0.26% of the 13F portfolio, value $460,064.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 7,313 shares
    Change vs previous 13F +761 shares

    0.21% of the 13F portfolio, value $753,631.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,552 shares
    Change vs previous 13F +6,455 shares

    0.11% of the 13F portfolio, value $463,734.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 97 shares
    Change vs previous 13F -8,259 shares

    <0.01% of the 13F portfolio, value $5,415.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 8,356 shares
    Change vs previous 13F +8,163 shares

    0.1% of the 13F portfolio, value $415,881.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 193 shares
    Change vs previous 13F +192 shares

    <0.01% of the 13F portfolio, value $8,758.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1 shares
    Change vs previous 13F -31,143 shares

    <0.01% of the 13F portfolio, value $39.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 31,144 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $956,428.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).